Search / 151 results found

from
to
  • Updated

THURSDAY, Jan. 27, 2022 (HealthDay News) -- Receipt of a third COVID-19 mRNA vaccine dose is associated with increased vaccine effectiveness against COVID-19 hospitalization, according to research published in the Jan. 28 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

  • Updated

THURSDAY, Jan. 27, 2022 (HealthDay News) -- Moderna Inc. announced Wednesday that it has launched a trial that will study the power of a redesigned booster shot -- one that homes in on the highly contagious omicron variant.

  • Updated

THURSDAY, Jan. 27, 2022 (HealthDay News) -- Despite a low absolute risk, there is an increased relative risk for carditis associated with BNT162b2 (Pfizer-BioNTech) vaccination, particularly among men and adolescents, according to a study published online Jan. 25 in the Annals of Internal Medicine.

  • Updated

THURSDAY, Jan. 27, 2022 (HealthDay News) -- Moderna Inc. announced Wednesday that it has launched a trial that will study the power of a redesigned booster shot -- one that hones in on the highly contagious Omicron variant.

  • Updated

WEDNESDAY, Jan. 26, 2022 (HealthDay News) -- Booster doses seem effective for the severe acute respiratory syndrome coronavirus 2 omicron variant, according to research published in the Jan. 21 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

  • Updated

TUESDAY, Jan. 25, 2022 (HealthDay News) -- Pfizer Inc. announced Tuesday that it has launched a trial that will compare its existing COVID-19 vaccine against a new version tailored to beat back the highly contagious omicron variant.